Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".

Iwata H, Murakami M, Maruo K, Nakamura M, Waki T, Nakamura M, Taguchi H, Inoue K, Araya M, Tatebe H, Satouchi M, Shimizu K, Hashimoto T, Harada H

Open source

DOI
10.1016/j.radonc.2026.111666
Published
2026 Oct
Container
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2026.111666,
  title = {Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".},
  author = {Iwata H and Murakami M and Maruo K and Nakamura M and Waki T and Nakamura M and Taguchi H and Inoue K and Araya M and Tatebe H and Satouchi M and Shimizu K and Hashimoto T and Harada H},
  year = {2026},
  journal = {Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  doi = {10.1016/j.radonc.2026.111666},
  url = {https://doi.org/10.1016/j.radonc.2026.111666}
}

RIS

TY  - JOUR
TI  - Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".
AU  - Iwata H
AU  - Murakami M
AU  - Maruo K
AU  - Nakamura M
AU  - Waki T
AU  - Nakamura M
AU  - Taguchi H
AU  - Inoue K
AU  - Araya M
AU  - Tatebe H
AU  - Satouchi M
AU  - Shimizu K
AU  - Hashimoto T
AU  - Harada H
PY  - 2026
JO  - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
DO  - 10.1016/j.radonc.2026.111666
UR  - https://doi.org/10.1016/j.radonc.2026.111666
ER  - 

APA

H, I., M, M., K, M., M, N., T, W., M, N., H, T., K, I., M, A., H, T., M, S., K, S., T, H., & H, H. (2026). Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2026.111666

Source records